Truist Financial Lowers Pediatrix Medical Group (NYSE:MD) Price Target to $16.00

Pediatrix Medical Group (NYSE:MD - Get Free Report) had its price objective lowered by equities researchers at Truist Financial from $18.00 to $16.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage presently has a "hold" rating on the stock. Truist Financial's price target points to a potential upside of 22.23% from the stock's current price.

MD has been the subject of a number of other research reports. Macquarie started coverage on shares of Pediatrix Medical Group in a research note on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective for the company. StockNews.com upgraded Pediatrix Medical Group from a "hold" rating to a "buy" rating in a report on Wednesday, January 22nd. Finally, UBS Group boosted their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research note on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat, Pediatrix Medical Group currently has a consensus rating of "Hold" and an average target price of $16.75.

Pediatrix Medical Group Price Performance

NYSE MD traded down $0.25 during trading hours on Friday, reaching $13.09. The company's stock had a trading volume of 158,457 shares, compared to its average volume of 836,664. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The company's 50-day moving average is $14.31 and its two-hundred day moving average is $13.94. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $17.67. The stock has a market cap of $1.12 billion, a PE ratio of -10.91, a PEG ratio of 1.74 and a beta of 1.32.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Thursday, February 20th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million. Analysts forecast that Pediatrix Medical Group will post 1.38 EPS for the current year.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently made changes to their positions in MD. SummerHaven Investment Management LLC lifted its position in shares of Pediatrix Medical Group by 0.9% during the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock worth $1,628,000 after purchasing an additional 1,028 shares during the last quarter. SG Americas Securities LLC increased its stake in Pediatrix Medical Group by 194.0% during the first quarter. SG Americas Securities LLC now owns 38,405 shares of the company's stock valued at $556,000 after purchasing an additional 25,343 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after buying an additional 1,765 shares during the last quarter. California State Teachers Retirement System grew its position in shares of Pediatrix Medical Group by 0.9% during the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after buying an additional 752 shares during the last quarter. Finally, Mackenzie Financial Corp acquired a new stake in Pediatrix Medical Group during the fourth quarter worth about $276,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.